Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. dyneelax

Dyneelax SIGNED

The world’s first automated laximetry device that replicates daily movements and activities through a dynamic test.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 Dyneelax project word cloud

Explore the words cloud of the Dyneelax project. It provides you a very rough idea of what is the project "Dyneelax" about.

treatment    stabilising    patients    cruciate    anterior    specialists    sme    practitioners    replacing    emergency    status    invasive    human    resonance    prioritise    standard    ligaments    core    automated    genourob    scans    joints    dynamic    quantitative    confirm    clinical    surveillance    medical    substitute    diagnose    recovery    wait    roadmap    automation    tests    ligament    motion    vital    limited    injury    laxity    reproducible    function    orthopaedist    periods    transform    quicker    healthy    contact    grant    standardisation    sometimes    looseness    ray    lachman    overcome    gps    specialist    point    unpredictable    mechanised    healthcare    injuries    examinations    diagnosing    magnetic    body    carries    entirely    device    laximetry    post    claim    protocol    instrument    mri    rotational    waiting    gold    completing    joint    scan    independent    market    fragile    exams    ideal    acl    contrast    dyneelax    diagnosis    mission    imaging    first    knee    prognosis    components   

Project "Dyneelax" data sheet

The following table provides information about the project.

Coordinator		 GENOUROB 

Organization address
address: BAT 60 RUE HENRI GERET
city: LAVAL
postcode: 53000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GENOUROB FR (LAVAL) coordinator 50˙000.00

Map

 Project objective

The knee is the largest, and one of the most complex and fragile joints in the human body, and the anterior cruciate ligament (ACL) is one of its core components. The ACL is vital to healthy knee function, stabilising the joint throughout its range of motion. In order to diagnose ACL injuries, the current gold standard is the Lachman’s test, which measures the ‘laxity’ (looseness) of the ligaments in the knee. Often done by hand, this is a reliable process when carried out by a specialist such as an orthopaedist. In contrast, general practitioners (GPs) and other non-specialists require x-ray or magnetic resonance imaging (MRI) exams to confirm their diagnosis. However, waiting periods for mechanised tests in the EU are long, sometimes entirely unpredictable, due to limited equipment availability and the need to prioritise emergency cases.

To overcome this, Genourob has developed Dyneelax, which is the first medical device for automated dynamic laximetry measurement. Dyneelax carries out objective and reproducible Lachman’s tests and rotational exams to assess the laximetry of the ACL. Automation and standardisation of this non-invasive, quantitative testing allows the diagnosis and prognosis of ACL injury and recovery status. It is independent of examinations such as x-ray and MRI scans and it can be used also by non-specialists such as GPs. This means quicker, more effective treatment for better recovery of patients.

At Genourob our mission is to transform the clinical protocol for diagnosing and prognosis of ACL injuries. In this way, GPs would be patients’ main point of contact with the healthcare system, replacing the need to wait for an MRI scan or x-ray for ACL injuries’ treatment. The SME Instrument grant is ideal for completing our product roadmap as it will enable our post-market surveillance to be carried out, to allow us to make the clinical claim that Dyneelax is an effective substitute for MRI scans in diagnosing and evaluating injuries to the ACL

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DYNEELAX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DYNEELAX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Click and Spray (2020)

A SIMPLER, CHEAPER AND EASIER TO RECYCLE AEROSOL CONTAINER

Read More  

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More